Market Size of Australia Veterinary Healthcare Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 9.75 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Australia Veterinary Healthcare Market Analysis
The Australia veterinary healthcare market is expected to reach a CAGR of 9.75% over the forecast period (2022-2027).
The Australia veterinary healthcare industry has been impacted by the effect of coronavirus, especially on the livestock segment. An unprecedented rise in pet ownership across the country has been seen post-COVID-19. There has been an increasing focus on veterinary telemedicine in the country, which is likely to have a positive impact on the market. According to the article titled ' impact of the COVID-19 pandemic on the welfare of animals in Australia' published in January 2021 some organizations, including Animal Health Australia (AHA), the Australian Veterinary Association (AVA) and the Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia, contacted the Australian Federal Department of Agriculture, water and Environemnt to request that veterinarians can be classified as an essential services. The Australian Veterinary Association (AVA) also re-affirmed that veterinarians could conduct telemedicine consulattaions in teh context of the COVID-19 pandemicm that will lead to increased veterinary teleconsultations and telepharmacy during the pandemic, thereby lead to increased adoption of tele veterinary services, driving the market growth.
The Australia veterinary healthcare market is projected to lead by advancements in health technology, leading to innovations in animal healthcare and increasing animal adoption in Australia, coupled with animal health spending. According to the Animal Medicine Australia 2021 Survey published in October 2021, Australian households own an estimated total of 6.3 million dogs and 4.9 million cats in the country. The high adoption of pets in Australian households eventually lead to increased adoption of veterinary healthcare services in Australia, thereby driving market growth.
Furthermore, a rise in collaborations between key market players and investments in veterinary health is also expected to drive the growth of this market. For instance, in November 2021, Merck Sharp & Dohme Corp (MSD) Animal Health, a division of Merck & Co., Inc., joined VetDB as an investor. In VetDB's third round of seed funding, MSD Animal Health joins the company's previous investors. VetDB's continuous growth and nationwide dissemination of its revolutionary medical technology will be aided by this financing. The rising investments by companies in the development of veterinary health technology are therefore expected to contribute to the market growth over the forecast period.
Therefore, the rising adoption of pets and the rise in investments in technological advancements in veterinary health, among other are expected to drive the growth of this market. However, there is a shift in the trend toward the use of counterfeit medicines for animal health, which is usually cheap, of low quality, and produced without adequate testing. These act as restraints for the market's growth.
Australia Veterinary Healthcare Industry Segmentation
As per the scope of this report, the Australia veterinary healthcare market is growing, and it comprises therapeutic and diagnostic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canines, felines, and equines. Farm animals include bovine, poultry, and porcine. The Australia Veterinary Healthcare Market is segmented on The Basis of Product (Therapeutics And Diagnostics) and Animal Type (Dogs And Cats, Horses, Ruminants, Swine, Poultry, and Other Animals). The report offers the value (in USD million) for the above segments.
By Product | |||||||
| |||||||
|
By Animal Type | |
Dogs and Cats | |
Horses | |
Ruminants | |
Swine | |
Poultry | |
Other Animal Types |
Australia Veterinary Healthcare Market Size Summary
The Australian veterinary healthcare market is experiencing significant growth, driven by a surge in pet ownership and advancements in veterinary telemedicine. The COVID-19 pandemic has highlighted the importance of veterinarians as essential services, leading to increased adoption of teleconsultations and telepharmacy. This shift has been supported by organizations such as the Australian Veterinary Association and the Royal Society for the Prevention of Cruelty to Animals, which have advocated for the continuation of these services. The market is further propelled by technological innovations in animal healthcare and rising animal adoption rates, which have led to increased spending on veterinary services. Collaborations and investments by key players, such as Merck Sharp & Dohme Corp's involvement with VetDB, are also contributing to market expansion.
The vaccine segment holds a significant share of the market, driven by innovations, increased awareness, and demand for animal protein. Initiatives to vaccinate pets against global pandemics and research grants to improve vaccine effectiveness in poultry are examples of developments boosting this segment. The market is dominated by major players like Zoetis Animal Healthcare and Merck Animal Health, with strategic acquisitions and partnerships enhancing their market presence. Despite challenges such as the use of counterfeit medicines, the overall market is expected to grow, supported by ongoing advancements and investments in veterinary health technology.
Australia Veterinary Healthcare Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increase In Animal Adoption Coupled with Increasing Awareness about Animal Healthcare
-
1.2.2 Advanced Technology in Animal Healthcare
-
-
1.3 Market Restraints
-
1.3.1 Use of Counterfeit Medicines
-
1.3.2 Increasing Costs of Animal Testing and Veterinary Care
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size - by Value)
-
2.1 By Product
-
2.1.1 Therapeutics
-
2.1.1.1 Vaccines
-
2.1.1.2 Parasiticides
-
2.1.1.3 Anti-infectives
-
2.1.1.4 Medical Feed Additives
-
2.1.1.5 Other Therapeutics
-
-
2.1.2 Diagnostics
-
2.1.2.1 Immunodiagnostic Tests
-
2.1.2.2 Molecular Diagnostics
-
2.1.2.3 Diagnostic Imaging
-
2.1.2.4 Clinical Chemistry
-
2.1.2.5 Other Diagnostics
-
-
-
2.2 By Animal Type
-
2.2.1 Dogs and Cats
-
2.2.2 Horses
-
2.2.3 Ruminants
-
2.2.4 Swine
-
2.2.5 Poultry
-
2.2.6 Other Animal Types
-
-
Australia Veterinary Healthcare Market Size FAQs
What is the current Australia Veterinary Healthcare Market size?
The Australia Veterinary Healthcare Market is projected to register a CAGR of 9.75% during the forecast period (2024-2029)
Who are the key players in Australia Veterinary Healthcare Market?
Zoetis Inc, Vetoquinol SA, Elanco, Merck Co. Inc. and Boehringer Ingelheim are the major companies operating in the Australia Veterinary Healthcare Market.